Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419

BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive variant of breast cancer that lacks the expression of estrogen and progesterone receptors (ER and PR) and HER2. Nearly 50% of patients with advanced TNBC will develop brain metastases (BrM), commonly with progressive extracranial dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Routh, Eric D., Van Swearingen, Amanda E. D., Sambade, Maria J., Vensko, Steven, McClure, Marni B., Woodcock, Mark G., Chai, Shengjie, Cuaboy, Luz A., Wheless, Amy, Garrett, Amy, Carey, Lisa A., Hoyle, Alan P., Parker, Joel S., Vincent, Benjamin G., Anders, Carey K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387304/
https://www.ncbi.nlm.nih.gov/pubmed/35992833
http://dx.doi.org/10.3389/fonc.2022.818693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387304/
https://www.ncbi.nlm.nih.gov/pubmed/35992833
http://dx.doi.org/10.3389/fonc.2022.818693

Ejemplares similares